论文部分内容阅读
目的:探讨布地奈德混悬液与可比特氧化吸入治疗婴幼儿哮喘的疗效。方法:将50例哮喘病婴幼儿平均分为研究组与对照组。对照组患儿应用布地奈德混悬液+病毒唑氧化吸入治疗,研究组患儿应用布地奈德混悬液+可比特氧化吸入治疗。结果:研究组治疗的总有效率为96.00%,显著高于对照组的76.00%(P<0.05)。结论:布地奈德混悬液与可比特氧化吸入治疗婴幼儿哮喘疗效显著,可以有效改善临床症状,安全性佳,适于临床应用。
Objective: To investigate the curative effect of budesonide suspension and cortical oxidative inhalation in the treatment of infantile asthma. Methods: 50 cases of asthma infants were equally divided into study group and control group. The control group of children with budesonide suspension + ribavirin inhalation therapy, the study group of children with budesonide suspension + bit oxidative inhalation therapy. Results: The total effective rate of the study group was 96.00%, significantly higher than 76.00% of the control group (P <0.05). Conclusion: The efficacy of budesonide suspension and cortisone inhalation in treating infantile asthma is significant, which can effectively improve clinical symptoms and safety, and is suitable for clinical application.